文献速递腹部泌尿生殖MRCT

MRI联合DWI可提高胰腺癌肝转移检出并优化手术候选者选择:系统综述与Meta分析

MRI with DWI improves detection of liver metastasis and selection of surgical candidates with pancreatic cancer: a systematic review and meta-analysis.
PubMed 文献 · Eur Radiol · 2023-08-11

该系统综述与Meta分析纳入9项研究共1121例患者,评估MRI联合DWI相比单独增强CT在胰腺癌术前评估中的价值。MRI联合DWI发现CT阴性的肝转移使无效手术比例降低6.0%(95%CI 3.0-11.6%),需治疗人数为16.6;改变治疗决策的比例为18.1%(95%CI 9.9-30.7%),需治疗人数为5.5;患者水平敏感度和特异度分别为92.4%(95%CI 87.4-95.6%)和97.3%(95%CI 96.0-98.1%)。结论认为MRI联合DWI可能通过提高CT上隐匿性肝转移的检出而避免无效手术。

要点

  • MRI联合DWI可检出增强CT阴性的肝转移,使无效手术比例降低6.0%(95%CI 3.0-11.6%)。
  • MRI联合DWI改变胰腺癌治疗决策的比例为18.1%(95%CI 9.9-30.7%),需治疗人数为5.5。
  • MRI联合DWI患者水平敏感度92.4%、特异度97.3%,其优势可能源于检出亚厘米肝转移。

核心结论

  • MRI联合DWI可能通过提高术前增强CT上隐匿性肝转移的检出而避免胰腺癌无效手术,需治疗人数为16.6。

研究设计与样本

  • 系统综述与Meta分析,检索MEDLINE、EMBASE和Cochrane数据库至2022年10月,纳入9项评估MRI联合DWI对比增强CT在新诊断胰腺癌术前评估中患者水平诊断性能的研究,共1121例患者。

关键影像表现/征象

  • MRI联合DWI对增强CT上隐匿的肝转移检出性能更高,可能归因于对亚厘米肝转移检出增加。
  • 1121例患者中172例(15.3%)有肝转移。

诊断标准与关键数值

  • MRI联合DWI患者水平敏感度92.4%(95%CI 87.4-95.6%),特异度97.3%(95%CI 96.0-98.1%)。
  • MRI联合DWI降低无效手术的比例为6.0%(95%CI 3.0-11.6%),需治疗人数为16.6。
  • MRI联合DWI改变治疗决策的比例为18.1%(95%CI 9.9-30.7%),需治疗人数为5.5。

临床应用与阅片要点

  • MRI联合DWI可作为胰腺癌术前增强CT评估肝转移的补充,以改善手术候选者选择并避免不必要手术。
  • 阅片时需关注增强CT阴性而MRI联合DWI阳性的肝转移,尤其是亚厘米病灶。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To perform a systematic review and meta-analysis to evaluate if magnetic resonance imaging (MRI) with diffusion weighted imaging (DWI) adds value compared to contrast-enhanced computed tomography (CECT) alone in the preoperative evaluation of pancreatic cancer.

METHODS: MEDLINE, EMBASE, and Cochrane databases were searched for relevant published studies through October 2022. Studies met eligibility criteria if they evaluated the per-patient diagnostic performance of MRI with DWI in the preoperative evaluation of newly diagnosed pancreatic cancer compared to CECT. Our primary outcome was the number needed to treat (NNT) to prevent one futile surgery using MRI with DWI, defined as those in which CECT was negative and MRI with DWI was positive for liver metastasis (i.e., surgical intervention in metastatic disease missed by CECT). The secondary outcomes were to determine the diagnostic performance and the NNT of MRI with DWI to change management in pancreatic cancer.

RESULTS: Nine studies met the inclusion criteria with a total of 1121 patients, of whom 172 had liver metastasis (15.3%). The proportion of futile surgeries reduced by MRI with DWI was 6.0% (95% CI, 3.0-11.6%), yielding an NNT of 16.6. The proportion of cases that MRI with DWI changed management was 18.1% (95% CI, 9.9-30.7), corresponding to an NNT of 5.5. The per-patient sensitivity and specificity of MRI were 92.4% (95% CI, 87.4-95.6%) and 97.3% (95% CI, 96.0-98.1).

CONCLUSION: MRI with DWI may prevent futile surgeries in pancreatic cancer by improving the detection of occult liver metastasis on preoperative CECT with an NNT of 16.6.

CLINICAL RELEVANCE STATEMENT: MRI with DWI complements the standard preoperative CECT evaluation for liver metastasis in pancreatic cancer, improving the selection of surgical candidates and preventing unnecessary surgeries.

KEY POINTS: • The NNT of MRI with DWI to prevent potential futile surgeries due to occult liver metastasis on CECT, defined as those in which CECT was negative and MRI with DWI was positive for liver metastasis, in patients with pancreatic cancer was 16.6. • The higher performance of MRI with DWI to detect liver metastasis occult on CECT can be attributed to an increased detection of subcentimeter liver metastasis.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Altmayer S, Armelin LM, Pereira JS, et al. MRI with DWI improves detection of liver metastasis and selection of surgical candidates with pancreatic cancer: a systematic review and meta-analysis. Eur Radiol. 2023. PMID: 37566274. doi:10.1007/s00330-023-10069-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。